BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12659624)

  • 1. Comment: caspofungin acetate for treatment of invasive fungal infections.
    Chan J
    Ann Pharmacother; 2003 Apr; 37(4):595. PubMed ID: 12659624
    [No Abstract]   [Full Text] [Related]  

  • 2. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Danaher PJ
    N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on antifungal therapy.
    Gigolashvili T
    Cancer Pract; 1999; 7(3):157-9. PubMed ID: 10352080
    [No Abstract]   [Full Text] [Related]  

  • 4. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A silver lining on the horizon: new antimycotics].
    Schäfer-Korting M; Holzgrabe U
    Pharm Unserer Zeit; 2003; 32(2):154-6. PubMed ID: 12677969
    [No Abstract]   [Full Text] [Related]  

  • 6. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
    Klastersky J
    N Engl J Med; 2004 Sep; 351(14):1445-7. PubMed ID: 15459307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic antifungal agents].
    Lumbreras C; Lizasoain M; Aguado JM
    Enferm Infecc Microbiol Clin; 2003; 21(7):366-79; quiz 380, 390. PubMed ID: 14525693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Schäfer-Korting M
    Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the use of antifungal agents.
    Martinez R
    J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
    Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical development of antimycotics. Medical challenges].
    Lipp HP
    Pharm Unserer Zeit; 2003; 32(2):144-52. PubMed ID: 12677968
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifungal agents in children.
    Steinbach WJ
    Pediatr Clin North Am; 2005 Jun; 52(3):895-915, viii. PubMed ID: 15925667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hope for patients with neoplastic disease and invasive fungal infections.
    McLeroth P; Polsky B
    J Support Oncol; 2005; 3(4):299-300. PubMed ID: 16092601
    [No Abstract]   [Full Text] [Related]  

  • 16. [Update on therapy of invasive mycoses in hematology and oncology].
    Maschmeyer G; Haas A; Böhme A
    Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
    [No Abstract]   [Full Text] [Related]  

  • 17. Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
    Guitard J; Degulys A; Buot G; Aline-Fardin A; Dannaoui E; Rio B; Marie JP; Lapusan S; Hennequin C
    Clin Microbiol Infect; 2014 Jan; 20(1):O30-2. PubMed ID: 23991697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
    Durand ML; Kim IK; D'Amico DJ; Loewenstein JI; Tobin EH; Kieval SJ; Martin SS; Azar DT; Miller FS; Lujan BJ; Miller JW
    Am J Ophthalmol; 2005 Sep; 140(3):552-4. PubMed ID: 16139017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antifungal drugs and new clinical trials: interpreting results may be difficult.
    Girmenia C; Martino P
    Curr Opin Oncol; 2003 Jul; 15(4):283-8. PubMed ID: 12874505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.